USA – FDA proposes framework for human factors information in device submissions

The US Food and Drug Administration (FDA) last week issued draft guidance outlining a risk-based framework about what human factors information should be included...

USA – FDA updates physiologic closed-loop control final guidance with industry feedback

The US Food and Drug Administration (FDA) has finalized guidance on physiologic closed-loop control (PCLC) technologies that includes several updates requested by medical device...
New guidance on biologics affects authorized generics

USA – FDA wants COVID test developers to shift from EUAs to traditional premarket...

The US Food and Drug Administration (FDA) has released updated guidance on COVID-19 diagnostic and serology testing, signaling its intention to review fewer emergency...
Coronavirus delays many FDA foreign inspections

USA – FDA finalizes COVID-era guidance on container closure changes

The US Food and Drug Administration (FDA) has finalized a guidance to assist sponsors in reporting common changes made to glass vials and stoppers,...
ANVISA will implement new rules for medical device modifications in Brazil

Brazil – ANVISA announces major medical device registration updates

Brazil’s medical device market regulator, ANVISA announced major updates to its Resolution of the Collegiate Board of Directors (RDC) 185/2001. The changes will serve...

USA – FDA warns consumers against using plastic syringes made in China

It’s not unusual for the US Food and Drug Administration (FDA) to publish warning letters about manufacturers that fail to meet its regulatory requirements,...

USA – Fall unified agenda includes new rule on removing outdated regulations, returning QMSR...

The Department of Health and Human Services (HHS) recently published the fall 2023 unified agenda for the US Food and Drug Administration (FDA) that...

USA – FDA issues final guidance on obtaining informed consent in drug and device...

The US Food and Drug Administration (FDA) on Tuesday announced it has finalized guidance to help institutional review boards (IRBs), clinical investigators, and sponsors...

USA – FDA concerned about potential device shortages due to new EtO limits

Rural and vulnerable populations could be placed at risk as the US Environmental Protection Agency (EPA) imposes new limits on the use of ethylene...

USA – Clinical Considerations for Studies of Devices Intended to Treat Opioid Use Disorder

The opioid epidemic is a serious and complex public health emergency facing the United States. The Agency has already taken significant steps to decrease...

NOS PROCHAINES FORMATIONS